Who is Sally Susman, and why does she want poor people to pay higher prices for medicines?

sally_without_film_0.jpg
Sally Susman of Pfizer leads the most lethal lobbying effort on drug patents and prices. She’s also a big Obama campaign fundraiser.

For several years, Pfizer has been considered a hardliner among big pharma companies on international negotiations over intellectual property rights and drug pricing. This has not changed despite the company having had three CEOs in the past five years.

Continue Reading

Uncategorized

Annotated Bibliography of Articles and Books on Innovation Prizes

This annotated bibliography of (mostly scholarly and technical) articles and books on innovation prizes is a work on progress. In the past few years, there has been an explosion of research on innovation inducement prizes, much of which has yet to be added to this list. People who want to suggest citations, annotations or corrections can send a note to james.love@keionline.org. More on prizes here: /prizes

2012

Continue Reading

Steve Ricchetti’s former clients, and Joe Biden

On March 12, 2012, Steve Ricchetti began his new job as a high level policy adviser to Vice President Biden. Steve Ricchetti is a former registered lobbyist, who de-listed as a registered lobbyist but remained the president of a lobbying firm until taking his new job in the White House.

Continue Reading

Uncategorized
1

KEI Statement on India’s granting of compulsory license to patents on cancer drug sorafenib (NATCO Vs. BAYER)

The India Controller General Controller General of Patents, Designs & Trade Marks has just (March 12, 2012) issued an order granting a compulsory license to patents on the cancer drug sorafenib/Nexavar, in the matter of NATCO Vs. BAYER. A copy of the decision is attached below.

Continue Reading

CCIA proposes alternative text for TPPA, but proposals do not address many problems in the text

The Computer & Communications Industry Association (CCIA) recently made proposals for what it considers to be necessary “to make the Internet work” in the Trans-Pacific Partnership Agreement. The proposals put forth either as additions or alternatives to some of what the US has tabled are, in general, a step in the right direction as they seek to improve copyright exceptions and limit liability. Continue Reading

Uncategorized

ACTA: US Intervention on IP Enforcement Trends at WTO Council for TRIPS (28 February 2012)

These are the interventions delivered by the United States of America on 28 February 2012 during WTO Council for TRIPS discussions on ACTA under “IP Enforcement Trends”.

N. IP ENFORCEMENT TRENDS

[U.S. First Intervention]

• We appreciate this opportunity to discuss enforcement of IP rights, and hopefully to dispel some misperceptions about IP enforcement in general and the ACTA in particular.

• Effective enforcement of intellectual property rights is critical to sustaining economic growth across all industries and globally.

Continue Reading

Uncategorized

28 Feb 2012: Intervention delivered by India at WTO TRIPS Council on IP Enforcement Trends noting concerns with ACTA and TPPA

This intervention was delivered by India at today’s WTO Council for TRIPS during discussions of agenda item “N” on IP Enforcement Trends. The statement raises India’s concerns with plurilateral agreements like ACTA and TPPA and their potential impacts on public health, international exhaustion, border measures and digital goods and internet freedom.

IP Enforcement Trends
(TRIPS council Feb 28, 2012)

Continue Reading

Uncategorized
© 2024 Knowledge Ecology International. All rights reserved.
Hiero by aThemes
steve_jeff_ricchetti.jpg